UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

BMC cancer, 2016-02, Vol.16 (168), p.168-168, Article 168

2016

Volltextzugriff (PDF)

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

British journal of cancer, 2011-09, Vol.105 (6), p.847-853

2011

Volltextzugriff (PDF)

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

Annals of oncology, 2018-02, Vol.29 (2), p.514-515

2018

Volltextzugriff (PDF)

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-03, Vol.35 (3), p.e245-e255

2023

Volltextzugriff (PDF)

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

Annals of oncology, 2019-04, Vol.30, p.ii79-ii80

2019

Volltextzugriff (PDF)

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

Cancer radiothérapie, 2022-09, Vol.26 (5), p.670-677

2022

Volltextzugriff (PDF)

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2018-10, Vol.29, p.viii508-viii509

2018

Volltextzugriff (PDF)

Management of a progressing prostate cancer: results of a national study

Progrès en urologie (Paris), 2017-05, Vol.27 (6), p.381-388

2017

Volltextzugriff (PDF)

2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting

European journal of cancer (1990), 2015-09, Vol.51, p.S489-S489

2015

Volltextzugriff (PDF)

2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel

European journal of cancer (1990), 2015-09, Vol.51, p.S488-S488

2015

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

Neuroendocrine carcinoma of the digestive tract: a literature review

La revue de medecine interne, 2013-11, Vol.34 (11), p.700-705

2013

Volltextzugriff (PDF)

Targeting KRAS pathway in NSCLC therapy

Bulletin du cancer, 2009-12, Vol.96 Suppl, p.S69

2009

Volltextzugriff (PDF)

Fever and cancer: components of diagnosis for optimal management

La revue de medecine interne, 2013-09, Vol.34 (9), p.545-552

2013

Volltextzugriff (PDF)

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

European journal of cancer (1990), 2011, Vol.47, p.S500-S500

2011

Volltextzugriff (PDF)

1375P Sequential ctDNA profiling in patients with advanced non-small cell lung cancer: An interim analysis of the COPE randomized study

Annals of oncology, 2024-09, Vol.35, p.S864-S864

2024

Volltextzugriff (PDF)

V070 - Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

European urology, 2023-02, Vol.83, p.S1974-S1974

2023

Volltextzugriff (PDF)

Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

European urology, 2023-02, Vol.83, p.S1974

2023

Volltextzugriff (PDF)

1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)

Annals of oncology, 2022-09, Vol.33, p.S1341-S1342

2022

Volltextzugriff (PDF)

Cancer chemotherapy of the upper aerodigestive tract

Cancer radiothérapie, 2008-03, Vol.12 (2), p.110-119

2008

Volltextzugriff (PDF)

IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

Annals of oncology, 2017-09, Vol.28, p.v417-v417

2017

Volltextzugriff (PDF)

MA25.03 Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S351-S352

2019

Volltextzugriff (PDF)

Fièvre et cancer : éléments de diagnostic pour une prise en charge adaptée

La revue de medecine interne, 2013-09, Vol.34 (9), p.545-552

2013

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(222)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(70)
Humans
(67)
Oncology
(50)
Male
(39)
Middle Aged
(29)
Aged
(27)
Female
(22)
Adult
(19)
Aged, 80 And Over
(18)
Lung Neoplasms - Drug Therapy
(18)
Life Sciences
(15)
Prostate Cancer
(15)
Sciences Biologiques Et Medicales
(15)
Sciences Medicales
(15)
Antineoplastic Agents - Therapeutic Use
(14)
Technology
(14)
Cancer
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)
Retrospective Studies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)

Management of a progressing prostate cancer: results of a national study

2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting

2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Neuroendocrine carcinoma of the digestive tract: a literature review

Targeting KRAS pathway in NSCLC therapy

Fever and cancer: components of diagnosis for optimal management

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

1375P Sequential ctDNA profiling in patients with advanced non-small cell lung cancer: An interim analysis of the COPE randomized study

V070 - Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial

Cancer chemotherapy of the upper aerodigestive tract

IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

MA25.03 Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients

Fièvre et cancer : éléments de diagnostic pour une prise en charge adaptée

Suchergebnisse filtern